Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page footer revision label was updated to v3.5.5, replacing the previous v3.5.4 and indicating a minor site/template update.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision label on the page updated to v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page template or accompanying content.SummaryDifference0.1%

- Check46 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version indicator is reflected at the bottom of the page.SummaryDifference0.1%

- Check53 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedPlatform revision updated from v3.4.2 to v3.4.3; no changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.